Piperidine derivatives as GCS inhibitors

Details for Australian Patent Application No. 2005205221 (hide)

Owner Actelion Pharmaceuticals Ltd

Inventors Orchard, Michael Glen; Scopes, David Ian Carter

Agent A J Park

Pub. Number AU-A-2005205221

PCT Pub. Number WO2005/068426

Priority 0400812.4 14.01.04 GB

Filing date 11 January 2005

Wipo publication date 28 July 2005

International Classifications

C07D 211/46 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/068426 Priority application(s): WO2005/068426

5 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005205224-Metallocene-based chiral phosphine or arsine ligands

2005205218-Methods of assessing a tissue inflammatory response using expression profiles of endothelial cells